<?xml version="1.0"?> 
<rss version="2.0">

	<channel>
		<title>Mylan N.V. (MYL) research, news, and more from GeoInvesting</title>
		<description>The latest research, news, and more from GeoInvesting for Mylan N.V. (MYL)</description>
		<link>/companies/myl_mylan_n_v_/overview</link>
		<language>en-us</language>
		<pubDate>Sun, 05 Apr 2026 15:12:41 GMT</pubDate>
		<lastBuildDate>Sun, 05 Apr 2026 15:12:41 GMT</lastBuildDate>
        <ttl>120</ttl>
        
        <item><title>Company description</title><guid isPermaLink="false">26355</guid><pubDate>Tue, 03 Aug 2010 04:00:00 GMT</pubDate><description>Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry&apos;s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world&apos;s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.</description><link>/companies/myl_mylan_n_v_/overview</link></item>
            
	
	</channel>  
	
</rss>
